Economic Evaluation of The Aranesp Application for Anemia Correction In Pathients With Chronical Renal Failure on Hemodialysis or Peritoneal Dialysis In Russia

to assess the cost effectiveness of the application of darbepoetin alfa vs other erythropoiesis-stimulating agents for anemia correction in patients on hemodialysis or peritoneal dialysis.

Source: Value in Health - October 23, 2015 Category: Global & Universal Authors: TS Fakeeva, I Krysanov Source Type: research